Oregon State University researchers have developed a new weapon in the battle against antibiotic-resistant germs – a molecule that neutralizes the bugs’ ability to destroy the antibiotic.
Scientists at OSU were part of an international collaboration that demonstrated the molecule’s ability to inhibit expression of an enzyme that makes bacteria resistant to a wide range of penicillins.
The molecule is a PPMO, short for peptide-conjugated phosphorodiamidate morpholino oligomer. The enzyme it combats is known as New Delhi metallo-beta-lactamase, or NDM-1, and it’s accompanied by additional genes that encode resistance to most if not all antibiotics.
“We’re targeting a resistance mechanism that’s shared by a whole bunch of pathogens,” said Bruce Geller, professor of microbiology in OSU’s College of Science and College of Agricultural Sciences, who’s been researching molecular medicine for more than a decade. “It’s the same gene in different types of bacteria, so you only have to have one PPMO that’s effective for all of them, which is different than other PPMOs that are genus specific.”
The Oregon State study showed that in vitro the new PPMO restored the ability of an antibiotic — in this case meropenem, an ultra-broad-spectrum drug of the carbapenem class — to fight three different genera of bacteria that express NDM-1. The research also demonstrated that a combination of the PPMO and meropenem was effective in treating mice infected with a pathogenic strain of E. coli that is NDM-1 positive.
Results of the study, supported by a grant from the National Institutes of Health, were recently published in the Journal of Antimicrobial Chemotherapy.
Geller says the PPMO will likely be ready for testing in humans in about three years.
“We’ve lost the ability to use many of our mainstream antibiotics,” Geller said. “Everything’s resistant to them now. That’s left us to try to develop new drugs to stay one step ahead of the bacteria, but the more we look the more we don’t find anything new. So that’s left us with making modifications to existing antibiotics, but as soon as you make a chemical change, the bugs mutate and now they’re resistant to the new, chemically modified antibiotic.”
That progression, Geller explains, made the carbapenems, the most advanced penicillin-type antibiotic, the last line of defense against bacterial infection.
“The significance of NDM-1 is that it is destroys carbapenems, so doctors have had to pull out an antibiotic, colistin, that hadn’t been used in decades because it’s toxic to the kidneys,” Geller said. “That is literally the last antibiotic that can be used on an NDM-1-expressing organism, and we now have bacteria that are completely resistant to all known antibiotics. But a PPMO can restore susceptibility to antibiotics that have already been approved, so we can get a PPMO approved and then go back and use these antibiotics that had become useless.”
Learn more: Molecule shows ability to thwart pathogens’ genetic resistance to antibiotic
[osd_subscribe categories=’antibiotic-resistance-5′ placeholder=’Email Address’ button_text=’Subscribe Now for any new posts on the topic “ANTIBIOTIC RESISTANCE”‘]
Receive an email update when we add a new ANTIBIOTIC RESISTANCE article.
The Latest on: Antibiotic resistance
[google_news title=”” keyword=”antibiotic resistance” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Antibiotic resistance
- Antibiotics use for acute sinusitis in children reduces treatment failures: Insights from meta-analysison May 12, 2024 at 8:29 pm
USA: Acute sinusitis is a common childhood ailment characterized by inflammation of the paranasal sinuses, often triggered by viral upper respiratory tract infections. While antibiotics have ...
- Warning of deadly drug-resistant disease on the rise across Dorseton May 12, 2024 at 8:22 pm
The Government has vowed to tackle the spread of a drug-resistant disease branded a "significant threat" to public health.
- In a new book, a scientist suggests ways to combat fast-spreading superbugs that defeat antibioticson May 12, 2024 at 5:00 pm
The story of antibiotics is a cautionary tale of a huge scientific triumph followed by great complacency. Today, antibiotic resistance is a silent, hidden pandemic, with profound consequences for ...
- ‘Diary of a Dying Girl’: A mother’s loss launches a global effort to fight antibiotic resistanceon May 12, 2024 at 10:30 am
Diane Shader Smith’s daughter, like thousands who die each year from drug-resistant infections, might have been saved if treatment came faster. Her mission now is to make sure it does.
- Warning over 'significant threat' drug-resistant disease on the rise in south Essexon May 12, 2024 at 4:26 am
The Government has vowed to tackle the spread of a drug-resistant disease branded a "significant threat" to public health.
- A mother’s loss launches a global effort to fight antibiotic resistanceon May 11, 2024 at 6:00 pm
Diary Of A Dying Girl” excerpts Mallory Smith's own writings, which chronicle her 13-year battle against an antibiotic-resistant lung infection.
- Tackling the hidden pandemic of antibiotic-resistant superbugson May 11, 2024 at 10:24 am
These superbugs then transfer some drug-defeating genes to other bacteria causing a pandemic of superbugs. It’s a vicious cycle. But water is not our only worry. Recent reports of the use of ...
- Stem cell treatments in Mexico linked to drug-resistant meningitis, joint infectionson May 9, 2024 at 12:35 pm
Antibiotic-resistant meningitis or severe, long-lasting joint infections: That's what three U.S. "medical tourists" brought home after seeking out unapproved stem cell treatments in Mexico, according ...
- A global effort to fight antibiotic resistanceon May 9, 2024 at 8:52 am
In November 2017, days after her daughter Mallory Smith died from a drug-resistant infection at the age of 25, Diane Shader Smith typed a password into Mallory’s laptop. Her daughter gave it to her ...
via Bing News